On 11 Jan. 65 Channel News AsiaReport Merck, a pharmaceutical company in the United States. Announcing the effectiveness of pills once morest COVID-19 Molnupiravir can fight COVID-19 New species, Omicron, including COVID-19 other species
“We are very confident that molnupiravir will be effective in the fight once morest Omicron. Molecular mechanisms of the drug will be able to work in omicron resistance. And I imagine the drug will also be able to fight other strains of coronavirus,” said Dean Lee, chair of the research lab atMerck Company The efficacy of molnupiravir was discussed at the JP Morgan Annual Healthcare Conference.
Merck’s latest efficacy data for molnupiravir was published in Nov.Molnupiravirin antimicrobialcovid omicron But from the data of 1,433 COVID-19 patients, it was found that molnupiravir It can reduce the number of people who need to be hospitalized and die by 30%.
However, the efficacy of molnupiravir in the fight once morest omikron must be regarded as diminished. because before Molnupiravir has been shown to reduce the number of severe cases and deaths by 50%. Several countries around the world, including the US Food and Drug Administration, the UK, Japan and India have approved it. Take pills once morest COVID-19 mole nupiravir Several countries have also entered into agreements to purchase the drug from Merck while India is still on the market.Molnupiravir tablets in pharmacies across the country so that people can buy and eat.